Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

erythro-Austrobailignan-6

Cat. No.: IBDI-430850

erythro-Austrobailignan-6 is an orally active anti-cancer agent. erythro-Austrobailignan-6 inhibits DNA topoisomerase I and II activity. erythro-Austrobailignan-6 induces cell apoptosis and increases phosphorylation of p38 and JNK.

Size (Solid):

Product Details

Target TopoisomeRase | Apoptosis
Molecular Weight 328.40
SMILES COC(C=C1C[[email protected]@H](C)[[email protected]@H](C)CC2=CC=C(OCO3)C3=C2)=C(C=C1)O
Structure Classification Phenylpropanoids>Lignans

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.